CHARACTERIZATION OF INFECTIONS IN PATIENTS WITH 22Q11.2 DELETION SYNDROME

Authors

  • Manuel Oliveira Pediatric Infecciology and Immunodeficiencies Unit, Department od Pediatrics of Centro Hospitalar do Porto
  • Carla Teixeira Pediatric Infecciology and Immunodeficiencies Unit, Department od Pediatrics of Centro Hospitalar do Porto
  • Júlia Vasconcelos Department of Immunology, Centro Hospitalar do Porto
  • Esmeralda Neves Department of Immunology, Centro Hospitalar do Porto
  • Sílvia Álvares Department of Pediatric Cardiology, Centro Hospitalar do Porto
  • Margarida Guedes Pediatric Infecciology and Immunodeficiencies Unit, Department od Pediatrics of Centro Hospitalar do Porto
  • Laura Marques Pediatric Infecciology and Immunodeficiencies Unit, Department od Pediatrics of Centro Hospitalar do Porto

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v22.i1.12887

Keywords:

mmunodeficiency, infections, 22q11.2 deletion

Abstract

Background: The 22q11.2 deletion syndrome (SD22q11.2) has an incidence of 1/2000 to 1/7000 live births. It is characterized by a variable degree of immunodeficiency that predisposes to infections, especially sino-pulmonary.
Material and Methods: A retrospective study of 12 patients with del22q11.2 de novo was performed, focusing on the immunological characteristics and the type and number of documented infections.
Results: The immunological studies showed one patient had severe T lymphopenia T and B lymphopenia with hypogammaglobulinemia associated with Evans syndrome, two patients had transient mild T lymphopenia, six had mild to moderate persistent T lymphopenia and three presented a normal immunological study. The mean incidence of infections was 0,5/year/patient (1,1/year/patient under age three). The most frequent were acute otitis media, pneumonia and bronchiolitis.
Discussion: There was a low number of infections/year/ patient, and these occurred mostly under the age of three years. The sino-pulmonary infections were the most documented and the evolution was generally benign. The transient and age-dependent nature of the immunological changes and the normal immune cell function, rather than the degree of T lymphopenia appear to contribute to this fact.

Downloads

Download data is not yet available.

References

Almeida R, Alvares S, Fortuna A, Moreira J, Vieira A. Associação

de Arco Aórtico Cervical a Delecção 22q11 - Papel da

RMN no Diagnóstico. Rev Port Cardiol 2003; 22:1241 -8.

Mastroiacovo P, Rossi P, Cancrini C, Azzari C, DiGilio MC,

Marino B, et al. Chromosome 22q.11 deletion - Recommendations

for Diagnosis and Treatment. Italian Primary Immunode

Þ ciencies Strategic ScientiÞ c Committee 2005. Disponível

em: http://www.aieop.org/stdoc/prot/rec_del22_en_06.pdf

Koshiyama DB, Rosa RM, Zen PR, Pereira VL, Graziadio C,

Coser VM, et al. Síndrome de deleção 22q11.2: importância

da avaliação clínica e técnica de FISH. Rev Assoc Med Bras

;55:442 -6.

Fernández L, Nevado J, Santos F, Heine -Suñer D, Martinez-

-Glez V, García -Miñaur S, et al. A deletion and a duplication in

distal 22q11.2 deletion syndrom region. Clinical implications

and review. BMC Med Genet 2009;10:48.

Bassett AS, Chow EWC, Husted J, Weksberg R, Caluseriu O,

Webb GD, Gatzoulis MA. Clinical features of 78 adults with

q11 deletion syndrome. Am J Med Genet A 2005;138:307-

-13.

Hay BN. Deletion 22q11: spectrum of associated disorders.

Semin Pediatr Neurol 2007;14:136.

Seroogy CM. DiGeorge syndrome: Evaluation, diagnosis,

and management. Disponível em: http://www.uptodate.com/

contents/digeorge -syndrome -evaluation -diagnosis -and-

-management

Seroogy CM. DiGeorge syndrome: Pathogenesis, epidemiology,

and clinical manifestations. Disponível em: http://www.

uptodate.com/contents/digeorge -syndrome -pathogenesis-

-epidemiology -and -clinical -manifestations

McLean -Tooke A, Barge D, Spickett GP, Gennery AR. Immunologic

defects in 22q11.2 deletion syndrome. J Allergy Clin

Immunol 2008;122:362 -7.

Bassett AS, McDonald -McGinn DM, Devriendt K, Digilio MC,

Goldenberg P, Habel A, et al. Practical Guidelines for Managing

Patients with 22q11.2 Deletion Syndrome. J Pediatr.

;159:332 -9.

Published

2017-08-22

How to Cite

1.
Oliveira M, Teixeira C, Vasconcelos J, Neves E, Álvares S, Guedes M, Marques L. CHARACTERIZATION OF INFECTIONS IN PATIENTS WITH 22Q11.2 DELETION SYNDROME. REVNEC [Internet]. 2017Aug.22 [cited 2024Dec.9];22(1):8-11. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/12887

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 3 4 5 > >>